Vrigaba-NTM Tablet
Marketer
Vridam Healthcare Pvt Ltd
Salt Composition
Pregabalin (75mg) + Nortriptyline (10mg) + Methylcobalamin (1500mcg)
Overview Vrigaba-NTM Tablet
Neuropathic pain is effectively managed by the combined medication, Vrigaba-NTM Tablet. Its mechanism involves modulating nerve cell calcium channel activity to reduce pain signals. Simultaneously, it elevates neurotransmitter levels in the brain, improving mood and safeguarding nerve fibers. Vrigaba-NTM Tablets may be administered with or without food, but consistent daily timing optimizes therapeutic levels. Adhere strictly to your physician's prescribed dosage and duration. Missed doses should be taken promptly upon recollection. Complete the entire course of treatment, even with symptom improvement. Abrupt cessation is discouraged due to potential symptom exacerbation. Common side effects include constipation, weight gain, and dry mouth. Dizziness and drowsiness may occur; avoid driving or activities requiring alertness until the medication's effects are known. Weight gain is possible; a balanced diet and regular exercise are recommended for management. Report any unusual mood or behavioral changes, new or worsening depression, or suicidal ideation to your doctor immediately. Prior to commencing treatment, disclose any kidney or liver conditions, and provide a complete list of all other medications being taken, as interactions may affect efficacy or drug metabolism. Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
Primary Ingredients of Vrigaba-NTM Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Vrigaba-NTM Tablet
Managing neuropathic pain
Major Benefits of Vrigaba-NTM Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Vrigaba-NTM Tablet whole; do not alter its form by chewing, crushing, or breaking it. This medication can be administered with or without food, although consistent timing is recommended.
Common Side effects of Vrigaba-NTM Tablet:
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Increased heart rate
- Difficulty in urination
- Decreased appetite
- Nausea
- Vomiting
- Constipation
- Weight gain
- Dizziness
- Sleepiness
- Tiredness
- Blurred vision
- Dryness in mouth
- Uncoordinated body movements
- Diarrhea
- Headache
How to use Vrigaba-NTM Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vrigaba-NTM Tablets can be consumed with or without food, although consistent timing is recommended.
How Vrigaba-NTM Tablet works:
Vrigaba-NTM tablets contain pregabalin, nortriptyline, and methylcobalamin, working synergistically to alleviate neuropathic pain. Pregabalin, an alpha-2-delta ligand, reduces pain by regulating nerve cell calcium channels. Nortriptyline, a tricyclic antidepressant, elevates serotonin and noradrenaline, neurotransmitters that inhibit pain signal transmission in the brain. Methylcobalamin, a vitamin B12 derivative, supports myelin production, protecting and repairing nerve fibers. This combined action provides effective neuropathic pain relief.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Vrigaba-NTM Tablet and alcohol may result in increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Using Vrigaba-NTM tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Employing Vrigaba-NTM tablets while breastfeeding is likely inadvisable. Available human data suggests potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Vrigaba-NTM Tablet side effects, due to potential drowsiness caused by the medication.
KidneyCAUTION
Patients with kidney impairment should use Vrigaba-NTM tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Use of Vrigaba-NTM Tablet in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Vrigaba-NTM Tablet :
Should you forget a Vrigaba-NTM Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vrigaba-NTM Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |




